EAGLE-1 trial offers hope of new oral treatment for gonorrhea The first-in-class antibacterial gepotidacin is noninferior to the standard first-line option in people with uncomplicated urogenital gonorrhea.

From #ESCMID25 - The first-in-class antibacterial #gepotidacin is noninferior to the standard first-line option in people with uncomplicated urogenital #gonorrhea.

Full story 👉 buff.ly/EWVHEkT

#MedSky #STIs #UroSky

IL-6 shows promise as diagnostic biomarker for sepsis in high-risk populations Interleukin-6 shows promise as a biomarker to diagnose sepsis early in high-risk patient groups such as neonates, children, and pregnant women.

From #ESCMID25 - Interleukin-6 shows promise as a biomarker to diagnose #sepsis early in high-risk patient groups such as neonates, children, and pregnant women.

Full story 👉 buff.ly/tE37ZvZ

#MedSky #IDSky #MedNews

On my way to Vienna and #escmid25